Share your videos with the world

Sign Up | Log In | Help  

Search // 43510
Results 1-1 of 1 for ' 43510 ' (0 seconds)
Boston Scientific Corporation (NYSE:BSX) announces U.S. Food and Drug Administration (FDA) approval for the PROMUS Element™ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System, the Company’s next-generation drug-eluting stent (DES) technology. The PROMUS Element Stent, designed to provide physicians improved DES performance in treating patients with coronary artery disease, is built on an innovative platinum chromium (PtCr) platform with the market-leading everolimus drug. The Company plans to begin marketing the product in the U.S. immediately. To view Multimedia News Release, go to
Categories // Science and Technology 
Added: 4384 days ago by MultiVuVideos
Runtime: 2m30s | Views: 5351 | Comments: 0
Not yet rated



Page 1 of 1  |  Go to page   

About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2023 All rights reserved.